-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Ardent Health, Raises Price Target to $18

Benzinga·11/06/2026 17:45:25
Listen to the news
RBC Capital analyst Ben Hendrix maintains Ardent Health (NYSE:ARDT) with a Outperform and raises the price target from $13 to $18.